Why This Landed on My Radar
CMS just announced they’re doubling the chronic conditions covered under the ACCESS model - adding COPD, substance use disorder, tobacco cessation, and one more track in spring 2027. If you’ve been watching how Medicare is increasingly tying reimbursement to outcomes rather than just encounters, this is the next chapter, and it’s moving faster than most of us expected. The early movers on this are going to have a significant advantage.
Here’s What’s Going On
The Trump administration is expanding Medicare’s Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) model from four covered conditions to eight, starting in spring 2027. This technology-based payment experiment shifts away from traditional fee-for-service toward outcomes-based reimbursement for chronic disease management.
The new clinical tracks will cover COPD, substance use disorder, and tobacco cessation - joining the existing conditions that launched with the model. This is CMS signaling where the puck is headed: they want technology-enabled, outcomes-driven chronic care management, and they’re willing to pay differently for it.
The ACCESS model is designed around remote monitoring, data analytics, and proactive intervention rather than reactive sick visits. Practices participating in the model get paid based on patient outcomes and engagement metrics, not just office visits and E&M codes. For those of us managing large panels of patients with multiple chronic conditions, this represents both a significant revenue opportunity and a fundamental shift in how we need to think about care delivery.
What This Means for Your Practice
Here in Texas, this hits differently than in states with robust Medicaid expansion and different payer mixes. We’ve got the nation’s largest uninsured population, but we also have massive Medicare and Medicare Advantage penetration - especially as our population ages and more beneficiaries shift to MA plans.
The expansion to COPD alone is huge for primary care. Look at your panel - how many patients do you have with COPD who cycle through the ER or get admitted for exacerbations that could have been prevented with better monitoring and earlier intervention? In rural Texas, where patients might drive 45 minutes for a visit, remote monitoring isn’t just convenient - it’s the difference between catching a decompensation early versus a hospital admission.
Substance use disorder and tobacco cessation are trickier for independent practices because they’ve traditionally been time-intensive and poorly reimbursed. But if CMS is creating an outcomes-based payment track with technology support built in, that changes the math entirely. These aren’t just “good to do” services anymore - they’re potential revenue centers if you have the right systems.
The V28 risk-adjustment changes already made accurate HCC capture more valuable for our MA contracts. Now CMS is layering on outcomes-based payments for chronic conditions that represent some of our highest-risk, highest-cost patients. The practices that can document comprehensively, manage proactively, and demonstrate outcomes improvement are going to see meaningfully better reimbursement.
The question is infrastructure. Most of us don’t have remote patient monitoring programs built out for COPD. We don’t have systematic tobacco cessation protocols with ongoing follow-up. We don’t have the care coordination resources for substance use disorder management. But if CMS is creating a payment model that supports these services, we need to figure out how to operationalize them - and quickly, before spring 2027.
Key Takeaways
- The ACCESS model expansion to eight chronic conditions represents CMS’s clearest signal yet that outcomes-based, technology-enabled chronic care is the future of Medicare reimbursement
- COPD, substance use disorder, and tobacco cessation will have dedicated payment tracks starting spring 2027 - all conditions where proactive management prevents costly downstream events
- This model rewards comprehensive documentation, risk stratification, and demonstrated outcomes improvement - exactly what V28 HCC accuracy already incentivizes in MA
- Practices that build remote monitoring and care coordination infrastructure now will have 18+ months to optimize before the new tracks launch
- For Texas practices with large Medicare/MA panels, this could represent significant new revenue if you can operationalize the care delivery model CMS is paying for
What Smart Practices Are Doing
The physicians I’m talking to who are ahead on this have already started piloting remote patient monitoring for their highest-risk chronic patients - starting with CHF and diabetes, then expanding to COPD. They’re treating 2025-2026 as a test period to work out the workflows, train staff, and prove out the outcomes before the new ACCESS tracks launch. By spring 2027, they’ll be ready to scale immediately while the rest of us are still figuring out vendor selection.
Source
CMS to add more chronic conditions to ACCESS model in 2027, Healthcare Dive
Primary Care Perspective delivers curated intelligence from trusted healthcare sources.
© 2026 Primary Care Perspective | Texas Edition